Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Transplantation
100%
Cyclophosphamide
100%
Multiple Myeloma
100%
Busulfan
100%
Phase I Study
100%
Chemotherapy
40%
Partial Response
20%
Disease Stage
20%
Pretransplant
20%
Treatment Toxicity
20%
Progenitor Cells
20%
Bone Marrow Cells
20%
Renal Toxicity
20%
Actuarial Survival
20%
Multiple Organ Failure
20%
Preparative Regimen
20%
Non-fatal
20%
Hepatic Toxicity
20%
Complete Response
20%
Myeloma
20%
Non-radiation
20%
Conditioning Regimen
20%
Bone Marrow Examination
20%
Minimal Responses
20%
β2-microglobulin (β2-MG)
20%
Resistant Disease
20%
Disease Response
20%
Blood Cells
20%
Venous Disease
20%
Monoclonal Paraprotein
20%
Total Dose
20%
Early Death
20%
Blood Progenitor
20%
Response to Chemotherapy
20%
Cell Transplant
20%
1-year Mortality
20%
95% Confidence Interval
20%
Bone Marrow Progenitor
20%
Skeletal Radiographs
20%
Medicine and Dentistry
Cyclophosphamide
100%
Multiple Myeloma
100%
Busulfan
100%
Transplantation Conditioning
100%
Diseases
60%
Chemotherapy
60%
Infection
20%
Infusion
20%
Multiple Organ Dysfunction Syndrome
20%
Myeloma
20%
Progenitor Cell
20%
Nephrotoxicity
20%
Vein Occlusion
20%
Blood Cell
20%
Paraprotein
20%
Hepatic Toxicity
20%